Sompraz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz HP ## Overview Sompraz HP is a combination product containing dexlansoprazole (a proton pump inhibitor) and amoxicillin and clarithromycin (antibiotics). It is designed for the eradication of *Helicobacter pylori* (*H. pylori*). Dexlansoprazole suppresses gastric acid production, creating an environment more conducive to antibiotic activity and healing. ## Primary Indications * Eradication of *Helicobacter pylori* (*H. pylori*) infection in patients with peptic ulcer disease. ## Adult Dosing The standard adult dose is one Sompraz HP kit taken twice daily for 10-14 days. Each kit contains: * Dexlansoprazole 60 mg delayed-release capsules * Amoxicillin 1000 mg capsules * Clarithromycin 500 mg tablets ## Pediatric Dosing There is **no established pediatric dosing** for Sompraz HP. Use in pediatric patients is not recommended. ## Dose Adjustments * **Renal Impairment:** No specific dose adjustment is recommended for dexlansoprazole. However, amoxicillin and clarithromycin are renally eliminated. Dose reduction and/or increased dosing interval may be necessary for amoxicillin and clarithromycin in severe renal impairment. Consult specific drug monographs for amoxicillin and clarithromycin for detailed guidance. * **Hepatic Impairment:** No specific dose adjustment is recommended for dexlansoprazole. Clarithromycin should be used with caution and may require dose reduction in patients with moderate to severe hepatic impairment. Consult specific drug monographs for amoxicillin and clarithromycin for detailed guidance. ## Contraindications * Known hypersensitivity to dexlansoprazole, amoxicillin, clarithromycin, or any component of the formulation. * History of severe hypersensitivity to other beta-lactam antibacterial agents (e.g., penicillin, cephalosporins). * History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use. * Concomitant use of ergotamine and dihydroergotamine. * Patients with a history of QT prolongation or ventricular arrhythmia. ## Adverse Effects **Common adverse effects associated with Sompraz HP include:** * **Gastrointestinal:** Diarrhea, nausea, abdominal pain, vomiting, taste perversion, dyspepsia. * **Other:** Headache, rash, fungal infections. **Serious adverse effects:** * *Clostridioides difficile*-associated diarrhea (CDAD) * Hypersensitivity reactions (including anaphylaxis) * Hepatotoxicity * QT prolongation, cardiac arrhythmias * Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) * *Amoxicillin-induced:* Hemolytic anemia, interstitial nephritis. ## Key Drug Interactions * **Clarithromycin:** * CYP3A4 inhibitors and inducers (significant interactions). * Colchicine: Increased colchicine levels. * Digoxin: Increased digoxin levels. * Ergot derivatives: Increased risk of ergotism. * HMG-CoA reductase inhibitors (statins metabolized by CYP3A4): Increased risk of myopathy. * Sildenafil: Increased risk of adverse effects. * **Dexlansoprazole:** * Methotrexate: May increase methotrexate levels. * Drugs dependent on gastric pH for absorption (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors): May decrease absorption. * Warfarin: May increase INR and bleeding risk. * **Amoxicillin:** * Allopurinol: Increased risk of rash. * Probenecid: May decrease renal excretion of amoxicillin. * Warfarin: May alter prothrombin time. ## Monitoring * **Treatment Efficacy:** Monitor for resolution of symptoms and confirm *H. pylori* eradication (typically 4-6 weeks after completion of therapy via stool antigen test or urea breath test). * **Adverse Effects:** Monitor for signs and symptoms of hypersensitivity reactions, *C. difficile*-associated diarrhea, liver dysfunction, rash, and GI upset. * **Renal and Hepatic Function:** Consider monitoring in patients with pre-existing renal or hepatic impairment, especially if prescribed for longer durations or if other risk factors are present. ## Clinical Pearls * This combination product is a fixed-dose regimen for *H. pylori* eradication. * Administer the entire contents of one Sompraz HP kit twice daily for 10-14 days. * Ensure patients understand the full course of therapy and take all medications as prescribed. * Inform patients about common side effects and when to seek medical attention. * Consider local resistance patterns for *H. pylori* when choosing empiric therapy. *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and guidelines for definitive guidance. Dosing and indications may vary.